Jing Zhu

Jing Zhu

Company: RVAC Medicines

Job title: Director, Process & Analytical Development


Case Study 4: Examining New Identity (ID) Assays for Multivalent mRNA Vaccines 3:15 pm

Identity (ID) assay required as both in-process and final releasing assays for mRNA vaccines Current progress and challenges of sequence methods as orthogonal approaches for multivalent mRNA ID assay Two newly developed ID methods demonstrated their advantages including shortened lead time, flexibility as a platform method and low requirement for in-house lab capacityRead more

day: Focus Day

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.